References
- Smith S D. Advances in the pharmacology of cancer chemotherapy. Pediatr Clin North Am 1981; 28: 145–160
- Meadows A T. Second malignant neoplasms. Late Effects in Successfully Treated Children with Cancer, M E Nesbit, Jr. Saunders, London 1985; Vol. 4: 247–267, Clinics in Oncology No. 2
- Pedersen-Bjergaard J, Larsen S O, Struck J, et al. Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 1987; ii: 83–88
- Heim S, Mitelman F. Primary chromosome abnormalities in human neoplasia. Adv Cancer Res 1989; 51, in press
- Oftedal P, Mulvihill J. Possible genetic effects of cancer therapy, seen in surviving cancer patients' offspring. Genetic Toxicology of Environmental Chemicals. Part B: Genetic Effects and Applied Mutagenesis, C Ramel, B Lambert, J Magnusson. Alan R. Liss, New York 1986; 351–356
- Schull W J. The genetic implications of long-term survival of childhood cancer. Mutation epidemiology. Am J Pediatr Hematol Oncol 1987; 9: 107–113
- Brøgger A, Nicolaysen R B, Nygaard R, et al. Structural chromosome aberrations in lymphocytes from children with one to five years of total remission after chemotherapy of acute lymphoblastic leukaemia. Eur Paediatr Haematol Oncol 1984; 1: 39–46
- Kolmannskog S, Moe P J, Besigye E, et al. Wilm's tumor with extension to the right atrium. Med Pediatr Oncol 1979; 6: 313–316
- Nakagome Y, Ise T, Sakurai M, et al. High-resolution studies in patients with aniridia-Wilms' tumor association, Wilms' tumor or related congenital abnormalities. Hum Genet 1984; 67: 245–248
- Bender M A, Awa A A, Brooks A L, et al. Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat 1988; 196: 103–159
- Abe S, Sasaki M. SCE as an index of mutagenesis and/or carcinogenesis. Sister Chromatid Exchange, A A Sandberg. Alan R. Liss, New York 1982; 579–617
- Gebhart E. Chromosomal aberrations in lymphocytes of patients under chemotherapy. Mutations in Man, G Obe. Springer-Verlag, Berlin 1984; 198–222
- Buckton K E, Hamilton G E, Paton L, . Chromosome aberrations in ankylosing spondylitis patients. Mutagen-Induced Chromosome Damage in Man, H J Evans, D C Lloyd, et al. Edinburgh University Press, Edinburgh 1978; 142–150
- Hansteen I-L, Hillestad L, Thiis-Evensen E, et al. Effects of vinyl chloride in man. A cytogenetic follow-up study. Mutat Res 1978; 51: 271–278
- Galloway S M, Berry P K, Nichols W W, et al. Chromosome aberrations in individuals occupationally exposed to ethylene oxide, and in a large control population. Mutat Res 1986; 170: 55–74
- Tawn E J. The frequency of chromosome aberrations in a control population. Mutat Res 1987; 182: 303–308
- Peterson H, Mitelman F. Nonrandom de novo chromosome aberrations in human lymphocytes and amniotic cells. Hereditas 1985; 102: 33–38
- Pimentel E. Hormones, Growth Factors, and Oncogenes. CRC Press, Boca Raton, Fla 1987; 10–11
- Heim S, Mitelman F. Nineteen of 26 cellular oncogenes precisely localized in the human genome map to one of the 83 bands involved in primary cancer-specific rearrangements. Hum Genet 1987; 75: 70–72
- Le Beau M M. Chromosomal fragile sites and cancer-specific rearrangements. Blood 1986; 67: 849–858